Charles Grob, MD
Disclosures: Nothing to disclose

Charles S. Grob, M.D. is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and the Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center.  He has conducted approved clinical research with psychedelics since the early 1990s.  From 2004-2008 he was the Principal Investigator of the first study in several decades to examine the utility of a psychedelic treatment model for patients with advanced-cancer anxiety.  He has also conducted research into the range of effects of MDMA, in both normal volunteers and (with co-investigator Alicia Danforth) in a selected subject population of adult autistics with severe social anxiety.  And, he has conducted a series of ayahuasca research studies, along with colleagues Dennis McKenna and J.C. Callaway, in Brazil.  Over the last thirty years Dr. Grob has published numerous articles on psychedelics in the medical and psychiatric literatures and he is the editor of Hallucinogens: A Reader (Putnam/Tarcher, 2002), co-editor (with Roger Walsh) of Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (SUNY Press, 2005) and co-editor (with James Grigsby) of the forthcoming Handbook of Medical Hallucinogens (Guilford Press, 2020).  He is also a founding board member of the Heffter Research Institute.